Funding · Company
Endeavor Biomedicines, Inc.
San Diego, CABiotech & Pharma
Endeavor Biomedicines, Inc. of San Diego, CA has disclosed $222M across 2 Form D offerings filed with the SEC between Feb 7, 2022 and May 3, 2024.
$222M
Total disclosed
2
Form D offerings
2018
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$89M
Form D · Feb 7, 2022 ↗
Q1 2022
· target $101M
Filing details
HeadquartersSan Diego, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2018SEC CIK0001909364Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →